LiveOne, Inc. (LVO)

Ligand Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	4.12	6.99	8.41	12.89	18.64
Cash & Short-Term Investments	4.12	6.99	8.41	12.89	18.64
Cash Growth	-41.05%	-16.91%	-34.78%	-30.81%	226.81%
Receivables	8.3	13.21	13.66	13.69	10.57
Inventory	1.59	1.8	2.6	2.6	2.57
Prepaid Expenses	1.21	2.19	2.82	1.87	3.37
Restricted Cash	0.03	0.16	0.24	0.26	0.14
Total Current Assets	15.25	24.34	27.73	31.31	35.27
Property, Plant & Equipment	0.99	3.73	3.75	5.42	4.37
Goodwill	21.71	23.38	23.38	23.38	22.62
Other Intangible Assets	2.57	12.42	11.04	16.72	22.47
Other Long-Term Assets	-	-	-	-	1.04
Total Assets	40.52	63.86	65.89	76.82	85.77
Accounts Payable	15.27	15.15	10.96	29.64	18.54
Accrued Expenses	15.4	22.57	24.37	29.04	26.14
Short-Term Debt	-	-	4.73	-	-
Current Portion of Long-Term Debt	3.57	7.69	0.02	0.01	4.71
Current Portion of Leases	-	0.09	0.27	0.27	0.32
Current Unearned Revenue	2.14	0.73	0.99	1.16	1.26
Other Current Liabilities	-	0.61	3.15	-	-
Total Current Liabilities	36.38	46.84	44.48	60.12	50.96
Long-Term Debt	0.15	0.77	7.15	26.64	19.43
Long-Term Leases	0.1	-	0.16	0.47	0.74
Long-Term Deferred Tax Liabilities	0.06	0.34	0.33	0.34	0.14
Other Long-Term Liabilities	12.24	9.35	9.95	0.17	6.36
Total Liabilities	48.93	57.31	62.07	87.74	77.63
Common Stock	0.1	0.09	0.09	0.08	0.08
Additional Paid-In Capital	233.5	216.12	209.15	202.85	178
Retained Earnings	-265.12	-238.98	-224.27	-213.85	-169.94
Treasury Stock	-0.25	-4.78	-2.16	-	-
Total Common Equity	-31.78	-27.56	-17.19	-10.92	8.14
Minority Interest	9.36	10.34	-	-	-
Shareholders' Equity	-8.41	6.56	3.81	-10.92	8.14
Total Liabilities & Equity	40.52	63.86	65.89	76.82	85.77
Total Debt	3.82	8.55	12.32	27.4	25.2
Net Cash (Debt)	0.3	-1.57	-3.91	-14.5	-6.56
Net Cash Per Share	0.00	-0.02	-0.05	-0.18	-0.10
Filing Date Shares Outstanding	96.97	95.1	87.22	83.03	77.55
Total Common Shares Outstanding	96.61	88.63	87.41	82.55	76.81
Working Capital	-21.14	-22.51	-16.75	-28.81	-15.69
Book Value Per Share	-0.33	-0.31	-0.20	-0.13	0.11
Tangible Book Value	-56.06	-63.35	-51.6	-51.02	-36.95
Tangible Book Value Per Share	-0.58	-0.71	-0.59	-0.62	-0.48
Machinery	3.16	7.12	7.06	5.65	5.42
Leasehold Improvements	0.6	0.6	0.53	0.53	0.53

Updated Jun 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q